Cala®, the bioelectronic medicine leader, today announced U.S. Food and Drug Administration (FDA) clearance of the Cala kIQ® Plus system, the next-generation of its wearable neurostimulation device ...

Cala announced today that it received FDA clearance for its kIQ Plus next-generation wearable neurostimulation device.

Parkinson’s disease ranks second among the most common age-related neurodegenerative brain diseases. Alzheimer’s is first.

Combining medication with physical therapy in the early stages of Parkinson’s disease can significantly slow its progression, according to ...

Patty Gille started experiencing symptoms that affected her daily life, and she immediately felt something was off. “My legs ...

Many people with Parkinson’s disease experience speech and swallowing difficulties that can weaken their voice or make them difficult to understand. Thanks to a grant from the Parkinson Voice Project, ...

For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms but do not truly repair the brain. That assumption is now under direct ...

Researchers at the University of Miami Miller School of Medicine are exploring stem cell treatments that could replace lost ...

PORCH Chattanooga, a local chapter of PORCH Communities, has teamed up with the International Student Leadership Council at UTC to plan a food drive after an urgent plea for donations to support ...

April is Parkinson's Disease Awareness Month, emphasizing early symptom recognition for timely diagnosis and improved patient ...